retatrutide clinical trial results 2025 Lilly's 'triple G' agonist triumphs in Phase III trial, but AEs unnerve analysts Lilly's triple agonist, retatrutide, demonstrated
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5




























